Cargando…
The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
Recombinant adeno-associated viral vectors (rAAVs) are among the most commonly used vehicles for in vivo based gene therapies. However, it is hard to predict which AAV capsid will provide the most robust expression in human subjects due to the observed discordance in vector-mediated transduction bet...
Autores principales: | Gonzalez-Sandoval, Adriana, Pekrun, Katja, Tsuji, Shinnosuke, Zhang, Feijie, Hung, King L., Chang, Howard Y., Kay, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147666/ https://www.ncbi.nlm.nih.gov/pubmed/37117181 http://dx.doi.org/10.1038/s41467-023-38106-3 |
Ejemplares similares
-
Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model
por: Song, Ren, et al.
Publicado: (2022) -
rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013) -
Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system
por: Galibert, Lionel, et al.
Publicado: (2018) -
Improving retinal vascular endothelial cell tropism through rational rAAV capsid design
por: Periasamy, Ramesh, et al.
Publicado: (2023)